Compare NIC & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NIC | TWST |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.0B |
| IPO Year | 2002 | 2018 |
| Metric | NIC | TWST |
|---|---|---|
| Price | $133.13 | $72.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $175.33 | $46.88 |
| AVG Volume (30 Days) | 124.9K | ★ 1.3M |
| Earning Date | 04-21-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.00% | N/A |
| EPS Growth | 21.49 | ★ 63.89 |
| EPS | ★ 0.81 | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | $43.96 | $18.91 |
| Revenue Next Year | $26.91 | $15.07 |
| P/E Ratio | $162.79 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $114.12 | $23.30 |
| 52 Week High | $163.11 | $72.99 |
| Indicator | NIC | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 33.73 | 70.38 |
| Support Level | $119.63 | $41.85 |
| Resistance Level | $136.05 | N/A |
| Average True Range (ATR) | 3.54 | 4.45 |
| MACD | -0.45 | 1.53 |
| Stochastic Oscillator | 1.54 | 96.28 |
Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.